欧林生物(688319.SH)拟收购控股子公司新诺明生物15%股权

Core Viewpoint - Olin Bio (688319.SH) announced that its subsidiary, XinNuoMing Bio, will transfer a total of 15% equity held by minority shareholders, Fund No.1 and JingChuang Fund, through a public transfer at the Southwest United Property Exchange [1] Group 1 - The company plans to acquire the 15% equity stake for no more than 45 million RMB, with a potential increase of up to 5% over the listed base price [1] - The acquisition includes 8.1081% equity from Fund No.1 and 6.8919% equity from JingChuang Fund [1] - This acquisition is expected to enhance the company's control and management efficiency over its subsidiary, contributing to overall strategic synergy and resource integration [1]